Skip to content

HHRI News & Press Releases

HHRI News & Press Releases

COVID-19 Test

Study identifies racial/ethnic and language inequities in ways patients obtain COVID-19 virus testing

July 13, 2021

The COVID-19 pandemic caused an unprecedented disruption to health care delivery, with resources shifted toward telehealth services and mass viral testing. While early studies in the pandemic highlighted differences in health care utilization among patients with commercial insurance, data from publicly insured or uninsured “safety-net” patient populations continue to emerge.…

Read More

Walz, Flanagan Announce Groundbreaking Partnership Between State of Minnesota, Health Care Systems on Race and Ethnicity Data Collection

March 5, 2021

— State announces additional, targeted strategies to promote equity in vaccination — The Walz-Flanagan Administration announced publication of vaccination data by race and ethnicity made possible through the groundbreaking partnership between the State of Minnesota and the Minnesota Electronic Health Record (EHR) Consortium. This unique and innovative collaboration between public…

Read More

Hennepin Healthcare takes a pulse of the pandemic

September 10, 2020

by hennepinmedical — COVID-19’s rapid arrival in Minnesota in March 2020 created myriad changes across the community – and a snapshot of that impact is now available in a report from Hennepin Healthcare. A collaboration for quality improvement between Hennepin Healthcare and Hennepin Healthcare Research Institute (HHRI) emerged to design…

Read More

Hennepin Healthcare collaborates with Mayo Clinic on convalescent plasma protocol as a therapeutic treatment for COVID-19 patients

June 25, 2020

Minneapolis, Minn. – Hennepin Healthcare Research Institute (HHRI) is collaborating with the Mayo Clinic to engage in a clinical protocol using convalescent plasma as a therapeutic treatment for COVID-19 patients. Convalescent plasma has appeared to be of benefit for the treatment of certain infectious diseases, including infections from respiratory viruses.…

Read More

Protected: Immune Therapy and Immunology

May 4, 2020

There is no excerpt because this is a protected post.

Read More

Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan

April 20, 2020

Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…

Read More

Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19

April 9, 2020

Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.  Hennepin Healthcare is a clinical site…

Read More
input search string and hit enter